ClinicalTrials.gg
RecruitingNCT07185828Updated Jul 23, 2026

Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)

An interventional study of Contact your PCP and Use Intelligent Triage in Emergency Service, Hospital and Behavior Change Interventions, sponsored by Geisinger Clinic. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-23.

Primary conditionnone(registry's first term: Emergencies)No conditionIs this wrong?Emergencies describes something many studies share rather than a condition a study is about. The study names no condition we can place it under, so it is not compared with other studies by condition.

Sponsored by Geisinger Clinic · Not applicable, Interventional, and Health services research

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
  • Registered 5 months after the study started (first participant enrolled Apr 2025, registered Sep 2025).
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
8,286
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this campaign is to reduce unnecessary visits to a Geisinger emergency department (ED). In this campaign, patients will be assigned to receive or not receive outreach following ED discharge with a low-acuity visit designation. Outreach will occur via a text message the day after discharge from the ED as well as information added to the patient's after visit summary (AVS). Depending on the assigned condition, it will include calls to see their primary care provider (PCP) or use an Intelligent Triage tool. The study will assess whether ED use within the following 120 days differs across patients in different outreach conditions (current standard practice vs contact your PCP vs use Intelligent Triage). It will also examine whether patients follow through on the message-specific calls to action differently across conditions.

02

Conditions studied

  • Emergency Service, Hospital
  • Behavior Change Interventions

Browse trials for

03

In context

Lead sponsor

Geisinger Clinic is the lead sponsor of 127 studies on the registry; 17 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 7 (78%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • >= 18 years of age
  • Geisinger ED visit rated as low acuity (L4 or L5)
  • Discharged from Geisinger ED in past 24 hours

Exclusion criteria

Exclusion Criteria:

  • Cannot be contacted via the communication modality being used in the study (i.e., SMS), due to insufficient/missing contact information in the EHR or because the patient opted out
  • Admitted to hospital
  • Already included in intervention in past 365 days
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
8,286 participants (estimated)

Study arms

  • No intervention
    Control

    This arm will receive no intervention outside of usual care.

  • Experimental
    Contact your PCP

    Intervention content emphasizes contacting a primary care provider (content will vary slightly based on whether the patient has a Geisinger PCP)

    Behavioral: Contact your PCP

  • Experimental
    Use Intelligent Triage

    Intervention content emphasizes using Intelligent Triage to assess symptoms.

    Behavioral: Use Intelligent Triage

Interventions

  • BehavioralContact your PCP

    Text messages will be sent and discharge paperwork will be modified to encourage contacting a primary care provider.

  • BehavioralUse Intelligent Triage

    Text messages will be sent and discharge paperwork will be modified to encourage using Intelligent Triage.

06

What researchers measure

Primary outcomes

  1. Return to Geisinger ED

    ED visit (yes/no)

    Time frame: within 120 days following day of discharge

Other outcomes

  1. PCP appointment made

    PCP appointment made (yes/no)

    Time frame: within 60 days following day of discharge

  2. PCP visit

    PCP appointment attended (yes/no)

    Time frame: within 60 days following day of discharge

  3. Telehealth appointment made

    Telehealth appointment made (yes/no)

    Time frame: within 60 days following day of discharge

  4. Telehealth appointment attended

    Telehealth appointment attended (yes/no)

    Time frame: within 60 days following day of discharge

  5. Call made to PCP

    Record of patient call to PCP (yes/no)

    Time frame: within 60 days following day of discharge

  6. Urgent care visit

    Urgent care appointment attended (yes/no)

    Time frame: within 60 days following day of discharge

  7. Used Intelligent Triage

    Used the Intelligent Triage tool (yes/no)

    Time frame: within 60 days following day of discharge

  8. Any of the suggested actions taken

    PCP called or visited, telehealth appointment attended, or PCP or telehealth appointment made, or Intelligent Triage tool used (yes/no)

    Time frame: within 60 days following day of discharge

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07185828
Lead sponsor
Geisinger Clinic
Responsible party
Amir Goren (Principal Investigator, Geisinger Clinic) — Principal investigator
First posted
Sep 22, 2025
Start date
Apr 15, 2025
Primary completion
Jul 2026 (estimated)
Completion
Jul 2026 (estimated)
Last update
Jul 23, 2026

Study contacts

Amir Goren, PhD
Contact
agoren@geisinger.edu
570-214-4395
Amir Goren, PhD
principal investigator · Geisinger Clinic

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion